Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Hamamatsu Photonics is a Japanese manufacturer of optical sensors, light sources, and imaging systems used in semiconductor manufacturing equipment, medical diagnostics, scientific research, and industrial automation. The company holds dominant market share in photomultiplier tubes (PMTs) and specialized detectors for high-end analytical instruments, with manufacturing concentrated in Japan and sales split roughly 50/50 between domestic and export markets. Stock performance tracks semiconductor capital equipment cycles, medical imaging demand, and yen/dollar exchange rates given significant USD-denominated revenue.
Hamamatsu generates revenue through direct sales of proprietary optical components and integrated systems, with pricing power derived from technical specifications unmatched by competitors in niche applications. The company captures value through vertical integration (in-house crystal growth, photocathode deposition, packaging) and long product qualification cycles that create switching costs for OEM customers. Gross margins of 45% reflect premium pricing on specialized detectors where performance requirements (quantum efficiency, timing resolution, noise characteristics) justify 2-3x cost premiums versus commodity alternatives. Repeat revenue comes from consumable components in installed systems and multi-year service contracts for high-end analytical equipment.
Semiconductor capital equipment spending cycles - particularly orders for wafer inspection and metrology tools that incorporate Hamamatsu sensors
Medical imaging equipment demand - CT scanner and PET scanner production volumes from customers like Siemens Healthineers, GE Healthcare, Canon Medical
Yen/dollar exchange rate - USD strengthening benefits translated earnings given 40-50% of revenue is export-denominated
New product cycle adoption rates - particularly next-generation silicon photomultipliers (SiPMs) displacing traditional PMTs in medical and LiDAR applications
China semiconductor equipment sales exposure - regulatory restrictions on advanced tooling exports impact revenue visibility
Technological substitution risk as CMOS image sensors and silicon photomultipliers displace traditional vacuum-tube photomultipliers in certain applications, compressing margins on legacy products
Semiconductor equipment cycle volatility - extreme boom-bust patterns in wafer fab equipment spending create revenue unpredictability despite diversification efforts
Geopolitical restrictions on semiconductor equipment sales to China, which represents meaningful portion of fab equipment demand and could face expanded export controls
Concentration in Japanese manufacturing creates supply chain vulnerability to natural disasters (earthquakes, tsunamis) and limits ability to serve customers requiring local production
Increasing competition from Chinese optical component manufacturers (e.g., Zolix, Daheng Optics) in lower-specification products, particularly for industrial automation applications
Vertical integration by large customers - semiconductor equipment makers like ASML and Applied Materials developing in-house sensor capabilities to reduce dependence on external suppliers
Technology platform shifts in medical imaging (e.g., shift from PET to alternative modalities) could obsolete specific product lines before R&D investments are recovered
Limited financial risk given conservative capital structure, though 0.4% FCF yield and $200M capex against $300M operating cash flow indicates heavy reinvestment requirements that constrain shareholder returns
Pension obligations typical of Japanese manufacturers may create unfunded liabilities, though not disclosed in available data
Working capital intensity during growth phases - semiconductor equipment orders require inventory builds and extended payment terms that can strain cash conversion
high - Revenue correlates strongly with global semiconductor capital equipment spending (which amplifies chip demand cycles) and medical equipment purchases that defer during economic downturns. Industrial production indices drive demand for process control sensors and quality inspection systems. The -99% YoY revenue decline suggests either data anomaly or severe cyclical downturn, though current fundamentals (45% gross margin, positive cash flow) indicate ongoing operations. Scientific research funding (government and academic) provides modest counter-cyclical stability but represents smaller revenue portion.
Rising rates create moderate headwinds through two channels: (1) Extended sales cycles as hospital systems and research institutions delay capital equipment purchases when financing costs increase, and (2) Valuation multiple compression typical for growth-oriented technology stocks. However, Hamamatsu's balance sheet strength (0.36 debt/equity, 1.94 current ratio) minimizes direct financing cost impact. Customer financing terms for large system sales may become less attractive in high-rate environments, potentially pressuring deal closure rates.
Minimal direct exposure - the company maintains net cash position and doesn't rely on credit markets for operations. Indirect exposure exists through customer financial health, particularly smaller research institutions and medical device startups that may struggle to secure equipment financing during credit contractions. Semiconductor fab customers (TSMC, Samsung, Intel) maintain strong credit profiles, limiting counterparty risk on large orders.
value/cyclical - The stock attracts investors seeking exposure to semiconductor equipment cycles and Japanese exporters benefiting from yen weakness, with 2.4x price/sales and 1.6x price/book suggesting modest valuation relative to technology peers. The -99% growth figures likely reflect data quality issues rather than actual business collapse given positive cash flow and margins. Patient value investors appreciate the company's technology moat in niche photonics applications and diversification across end markets. Limited analyst coverage and ADR liquidity constraints mean the stock primarily attracts specialized Japan-focused funds and technology sector specialists.
high - Stock exhibits elevated volatility driven by semiconductor cycle swings, yen exchange rate fluctuations (20-30% annual moves not uncommon), and limited ADR trading liquidity. Beta likely exceeds 1.2 relative to broader technology indices during semiconductor upcycles. The 13.7% three-month return versus -5% six-month performance illustrates typical volatility patterns. Quarterly earnings can trigger 10-15% single-day moves given limited float and analyst coverage.
